Participants
Subjects were 15 pharmacoresistant, surgically non-treatable epilepsy
patients (Mage = 36.9 years, range: 17–64; 7 females)
participating in the ANT deep brain stimulation (DBS) protocol at the
National Institute of Mental Health, Neurology and Neurosurgery,
Budapest, Hungary. Clinical and demographic data are reported in Table
1. The research was approved by the ethical committee of the National
Institute of Mental Health, Neurology and Neurosurgery. Patients signed
informed consent for participating in the study. General intelligence
(IQ) was measured prior to the surgery by Wechsler Adult Intelligence
Scales, 4th edition IQ from 11 patients who underwent on
neuropsychological testing in the context of their clinical routine
presurgical assessment.